Search

everythinglearnresearchcommunity

for

Search:↓

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Balancing hormones can help women feel youthful and healthy.

3D-oxy exosomes may significantly boost hair growth, offering new treatment options for hair loss.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Most female students at Qassim University know about PCOS, but there are still misunderstandings about it.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.